Skye Bioscience Stock (NASDAQ:SKYE), Quotes and News Summary

Q: What sector and industry does Skye Bioscience (SKYE) operate in?

Skye Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Skye Bioscience Stock (NASDAQ: SKYE) stock price, news, charts, stock research, profile.

Open	$13.650
Close	$12.850
Volume / Avg.	108.918K / 40.667K
Day Range	12.500 - 14.100
52 Wk Range	1.440 - 19.410
Market Cap	$360.608M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	0.21%
Days to Cover	1.42

Recent News

Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Skye Bioscience And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Skye Secures $17M And Acquires Novel Phase 2-Ready Cannabinoid 1 Receptor Inhibitor

Skye Bioscience, Inc. (OTCQB: SKYE) has undertaken a strategic initiative that expands the company's resources and technologies focused on developing therapeutic products focused on the endocannabinoid system ("ECS").

Vuk Zdinjak

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.6

Strong Buy

Buy

Hold

Sell

Strong Sell

About Skye Bioscience Inc

Sector

Health Care

Industry

Biotechnology

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The c...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Skye Bioscience (SKYE) stock?

You can purchase shares of Skye Bioscience (NASDAQ: SKYE) through any online brokerage.

View our list of the best stock brokerages.

Who are Skye Bioscience's (SKYE) competitors?

Other companies in Skye Bioscience’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL), PepGen (NASDAQ:PEPG) and Anika Therapeutics (NASDAQ:ANIK).

What is the target price for Skye Bioscience (SKYE) stock?

The latest price target for Skye Bioscience (NASDAQ: SKYE) was reported by Oppenheimer on Friday, April 12, 2024. The analyst firm set a price target for 25.00 expecting SKYE to rise to within 12 months (a possible 94.55% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Skye Bioscience (SKYE)?

The stock price for Skye Bioscience (NASDAQ: SKYE) is $12.85 last updated April 24, 2024 at 4:00 PM EDT.

Does Skye Bioscience (SKYE) pay a dividend?

There are no upcoming dividends for Skye Bioscience.

When is Skye Bioscience (NASDAQ:SKYE) reporting earnings?

Skye Bioscience does not have any upcoming earnings scheduled.

Is Skye Bioscience (SKYE) going to split?

There is no upcoming split for Skye Bioscience.

What sector and industry does Skye Bioscience (SKYE) operate in?

Skye Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-